CT-P43

BIOLOGICAL3 trials

Sponsors

Celltrion

Conditions

Healthy Male SubjectsHealthy SubjectsPsoriasis

Phase 1

Study to Compare PK and Safety of Subcutaneous Injection of Ustekinumab and CT-P43 in Healthy Subjects

CompletedNCT04428814

CelltrionHealthy Subjects

Start: 2020-08-03End: 2021-02-24Updated: 2021-08-05

A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P43 in Healthy Male Subjects

CompletedNCT06951828

CelltrionHealthy Male Subjects

Start: 2025-05-30End: 2025-12-24Updated: 2026-02-24

Phase 3

A Study to Compare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque Psoriasis

CompletedNCT04673786

CelltrionPsoriasis

Start: 2021-01-11End: 2022-05-12Updated: 2023-06-05

Related Papers

Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study

BioDrugs2023-11-2221 citations